Literature DB >> 17014937

Role of T lymphocyte replicative senescence in vaccine efficacy.

Rita B Effros1.   

Abstract

Immunological changes associated with aging play a major role in both the blunted responses to infections as well as to vaccines intended to prevent many of these infections. Several independent studies on immune correlates of poor vaccine responsiveness have identified a novel immune biomarker of reduced antibody response to vaccination, namely high proportions of memory CD8 T lymphocytes lacking expression of the CD28 costimulatory molecule. Research on this population of CD8(+)CD28(-) T lymphocytes has documented characteristics suggestive of replicative senescence, including inability to proliferate, reduced telomere length, and altered cytokine profiles. CD8(+)CD28(-) T lymphocytes have also been associated with suppressor functions and with early mortality in the elderly. This article discusses some of the challenges involved in custom-designing vaccines for the elderly, and suggests several immunomodulatory strategies that may enhance vaccine responsiveness in this age group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17014937     DOI: 10.1016/j.vaccine.2006.08.032

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  60 in total

1.  Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities.

Authors:  Rania A Tohme; Debo Awosika-Olumo; Carrie Nielsen; Salma Khuwaja; Jennifer Scott; Jian Xing; Jan Drobeniuc; Dale J Hu; Cynthia Turner; Toni Wafeeg; Umid Sharapov; Philip R Spradling
Journal:  Vaccine       Date:  2011-10-18       Impact factor: 3.641

2.  Predicting cytotoxic T-cell age from multivariate analysis of static and dynamic biomarkers.

Authors:  Catherine A Rivet; Abby S Hill; Hang Lu; Melissa L Kemp
Journal:  Mol Cell Proteomics       Date:  2010-12-30       Impact factor: 5.911

3.  Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence.

Authors:  Jeffrey N Dock; Rita B Effros
Journal:  Aging Dis       Date:  2011-10       Impact factor: 6.745

Review 4.  The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.

Authors:  Janet E McElhaney; Xin Zhou; H Keipp Talbot; Ernst Soethout; R Chris Bleackley; David J Granville; Graham Pawelec
Journal:  Vaccine       Date:  2012-01-27       Impact factor: 3.641

5.  Cardiovascular exercise intervention improves the primary antibody response to keyhole limpet hemocyanin (KLH) in previously sedentary older adults.

Authors:  R W Grant; R A Mariani; V J Vieira; M Fleshner; T P Smith; K T Keylock; T W Lowder; E McAuley; L Hu; K Chapman-Novakofski; J A Woods
Journal:  Brain Behav Immun       Date:  2008-03-04       Impact factor: 7.217

Review 6.  The ageing immune system: is it ever too old to become young again?

Authors:  Kenneth Dorshkind; Encarnacion Montecino-Rodriguez; Robert A J Signer
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

Review 7.  [Immunosenescence. Current status and molecular mechanisms].

Authors:  T Peters
Journal:  Hautarzt       Date:  2011-08       Impact factor: 0.751

8.  Interleukin-7 inhibits tumor-induced CD27-CD28- suppressor T cells: implications for cancer immunotherapy.

Authors:  Yue Zhang; Lukas W Pfannenstiel; Elzbieta Bolesta; Carolina L Montes; Xiaoyu Zhang; Andrei I Chapoval; Ronald B Gartenhaus; Scott E Strome; Brian R Gastman
Journal:  Clin Cancer Res       Date:  2011-06-28       Impact factor: 12.531

9.  Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines.

Authors:  Janet E McElhaney
Journal:  Aging health       Date:  2008-12-01

Review 10.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.